Navigation Links
Dr. Adrienne C. Scheck, Ph.D. is recognized by Continental Who's Who as a Pinnacle Professional
Date:8/7/2013

PHOENIX, Aug. 7, 2013 /PRNewswire/ -- Dr. Adrienne C. Scheck, Ph.D. is recognized by Continental Who's Who as a Pinnacle Professional in the field of Scientific Research as a result of her role as a Principle Investigator with Barrow Neurological Institute (BNI), the world's largest neurological disease treatment and research institution.

Barrow Neurological Institute (BNI) at St. Joseph's Hospital and Medical Center is the world's largest dedicated neurosurgical center and a leader in neurosurgical training, research, and patient care. More operative neurosurgical procedures take place at Barrow than at any other institution in the United States.

As a Principle Investigator, Dr. Scheck specializes in research involving metabolic and standard care therapies; brain tumor therapy; therapy resistance; and the development of new prognostic markers for brain tumors. Her research helps to develop novel adjuvant therapies for the treatment of brain tumors through the use of various molecular and molecular genetics techniques to investigate why current therapies sometimes fail.

Dr. Scheck currently serves on the Board of Directors and as Past Board Chair of Southwest Behavioral Health Services and on the Advisory Board for Arizona's First Science and Technology Expo.  In addition, she is a member of the American Association for Cancer Research and the Society for Neuro-Oncology. She also maintains her position as a reviewer for a number of Professional Journals and is on the Editorial Board of Cancer Genetics and Cytogenetics, CNS Oncology and World Journal of Surgical, Medical and Radiation Oncology.

Dr. Scheck earned a Ph.D. in Biology from Rensselaer Polytechnic Institute as well as a B.A. in Biology from the University of Rochester.

For more information, please visit http://www.thebarrow.org/Research/Neuro_Oncology/index.htm.

About Us

Continental Who's Who has become one of the most respected and trusted publishers around the globe.  We spotlight thousands of professional individuals and organizations each year who "stand-out" in their specific field.  Included are executives and officials in business, science, education, philanthropy, religion, government, the fourth estate, finance, law, engineering, authors, the musically talented elite as well as numerous additional industries.

Our mission at Continental Who's Who is to provide an exclusive internationally recognized world-class forum where members can create social, professional and business relationships.  We provide resources, information and represent an atmosphere and opportunity to network, consult, showcase, educate, and empower, allowing for establishing new business relations to increase future success.  We are committed to delivering the highest quality service to all our established members.

Please visit us at www.continentalwhoswho.com

Contact: Robert Basilin, 516-825-5634 pr@continentalwhoswho.com


'/>"/>
SOURCE Continental Who's Who
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia
2. Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.
3. Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
4. USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala
5. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)
6. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
7. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
8. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
9. Three Executives from inVentiv Health Clinical and Communications Recognized on Prestigious List of PharmaVOICE 100 Industry Leaders
10. Adeptia Recognized as a Niche Player in 2013 Magic Quadrant for Data Integration Tools
11. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2018)... ... August 17, 2018 , ... VANCOUVER, British Columbia, Canada, August ... pleased to announce the release of the Russian translation of Best Practices: Recommendations ... 2018, is a practice-changing publication aimed at advancing the science of biobanking to ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... impetus at the 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) ... Fule Science & Technology Development , Beijing, and Invibio Biomaterial Solutions ...
(Date:8/9/2018)... ... 2018 , ... ActX introduces GenoACT(sm), a Genetic Clinical Decision ... talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by ... medical impact of a patient’s genetic variants , 2. Educational information for clinicians, ...
(Date:8/9/2018)... ... 09, 2018 , ... MedEvolve, Inc. , a national ... software and services for physician practices, announced today the company’s bookings for second ... record quarters in Q2 and Q3 last year, the company has exceeded those ...
Breaking Biology Technology:
(Date:8/2/2018)... ... August 02, 2018 , ... RxS LLC (“RxS”), a ... today announced that Mark Jara, principal of the organization, has been named to ... industry. Individuals named to PharmaVOICE 100 are leaders who drive the industry forward ...
(Date:8/1/2018)... ... August 01, 2018 , ... Clinical ... LPN’s, MA's and Administrative staff. , This full day course is an interactive ... course will expose your staff to regenerative medicine procedures and processing techniques, and ...
(Date:7/31/2018)... ... 31, 2018 , ... Lifecycle Biotechnologies, a leading life science ... this role, Mr. Muzek will lead the company-wide industrial strategic business development efforts ... , With over 20 years in business development, Mr. Muzek previously served as ...
Breaking Biology News(10 mins):